D.E. Shaw & Co’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.3M | Buy |
1,572,983
+40,710
| +3% | +$595K | 0.02% | 1055 |
|
|
2025
Q4 | $24.4M | Buy |
1,532,273
+622,351
| +68% | +$8.82M | 0.02% | 1125 |
|
|
2025
Q3 | $10.1M | Buy |
909,922
+568,382
| +166% | +$6.21M | 0.01% | 1684 |
|
|
2025
Q2 | $2.89M | Buy |
341,540
+77,117
| +29% | +$618K | ﹤0.01% | 2454 |
|
|
2025
Q1 | $2.13M | Buy |
264,423
+131,090
| +98% | +$1.06M | ﹤0.01% | 2561 |
|
|
2024
Q4 | $1.2M | Buy |
133,333
+39,384
| +42% | +$321K | ﹤0.01% | 3101 |
|
|
2024
Q3 | $689K | Buy |
93,949
+8,055
| +9% | +$49.9K | ﹤0.01% | 3513 |
|
|
2024
Q2 | $490K | Buy |
85,894
+4,152
| +5% | +$21.9K | ﹤0.01% | 3634 |
|
|
2024
Q1 | $410K | Sell |
81,742
-10,820
| -12% | -$73.4K | ﹤0.01% | 3582 |
|
|
2023
Q4 | $832K | Sell |
92,562
-264,584
| -74% | -$2.18M | ﹤0.01% | 3257 |
|
|
2023
Q3 | $2.78M | Sell |
357,146
-256,367
| -42% | -$2.51M | ﹤0.01% | 2313 |
|
|
2023
Q2 | $5.94M | Buy |
613,513
+108,259
| +21% | +$1.12M | 0.01% | 1736 |
|
|
2023
Q1 | $5.54M | Buy |
505,254
+398,970
| +375% | +$3.51M | 0.01% | 1843 |
|
|
2022
Q4 | $459K | Buy |
106,284
+6,447
| +6% | +$37.4K | ﹤0.01% | 3898 |
|
|
2022
Q3 | $751K | Sell |
99,837
-13,723
| -12% | -$119K | ﹤0.01% | 3794 |
|
|
2022
Q2 | $1.14M | Buy |
113,560
+34,647
| +44% | +$387K | ﹤0.01% | 3542 |
|
|
2022
Q1 | $977K | Sell |
78,913
-109,420
| -58% | -$1.69M | ﹤0.01% | 3937 |
|
|
2021
Q4 | $4.31M | Sell |
188,333
-145,536
| -44% | -$3.45M | 0.01% | 2546 |
|
|
2021
Q3 | $7.39M | Buy |
333,869
+294,258
| +743% | +$4.67M | 0.01% | 1764 |
|
|
2021
Q2 | $513K | Buy |
39,611
+27,776
| +235% | +$354K | ﹤0.01% | 4026 |
|
|
2021
Q1 | $154K | Sell |
11,835
-289,198
| -96% | -$4.2M | ﹤0.01% | 3893 |
|
|
2020
Q4 | $4.16M | Sell |
301,033
-38,006
| -11% | -$553K | 0.01% | 2014 |
|
|
2020
Q3 | $4.99M | Buy |
339,039
+222,073
| +190% | +$3.22M | 0.01% | 1690 |
|
|
2020
Q2 | $1.9M | Sell |
116,966
-5,672
| -5% | -$90.8K | ﹤0.01% | 2449 |
|
|
2020
Q1 | $1.78M | Buy |
+122,638
| New | +$2.16M | ﹤0.01% | 2261 |
|
|
2019
Q4 | – | Sell |
-335,027
| Closed | -$1.79M | – | 3953 |
|
|
2019
Q3 | $1.79M | Sell |
335,027
-58,273
| -15% | -$353K | ﹤0.01% | 2439 |
|
|
2019
Q2 | $2.59M | Sell |
393,300
-154,898
| -28% | -$987K | ﹤0.01% | 2056 |
|
|
2019
Q1 | $3.56M | Buy |
548,198
+159,387
| +41% | +$1.06M | 0.01% | 1774 |
|
|
2018
Q4 | $2.65M | Buy |
388,811
+124,940
| +47% | +$720K | ﹤0.01% | 1926 |
|
|
2018
Q3 | $1.75M | Buy |
263,871
+148,399
| +129% | +$832K | ﹤0.01% | 2291 |
|
|
2018
Q2 | $650K | Sell |
115,472
-117,161
| -50% | -$654K | ﹤0.01% | 2956 |
|
|
2018
Q1 | $1.21M | Buy |
+232,633
| New | +$1.24M | ﹤0.01% | 2365 |
|
Other funds holding AUPH
TCM
NMC
